Supadopa TR 95 mg is an extended-release capsule combining Levodopa and Carbidopa, designed to manage symptoms of Parkinson's disease and related movement disorders. Levodopa serves as a precursor to dopamine, replenishing diminished levels in the brain, while Carbidopa inhibits peripheral metabolism of Levodopa, enhancing its availability to the central nervous system and reducing side effects like nausea. The extended-release formulation ensures a sustained therapeutic effect, aiding in smoother motor control throughout the day.